Navigation Links
iSirona Appoints Chief Quality and Regulatory Officer to Oversee Quality Initiatives
Date:4/26/2010

Samuel Patton to Spearhead Company's Quality, Regulatory and Compliance Matters

Panama City, Fla. (PRWEB) April 26, 2010 -- iSirona®, a provider of simplified solutions for medical device integration, today announced the appointment of Samuel Patton as the company’s chief quality and regulatory officer. He will spearhead the company’s quality initiatives and oversee all regulatory and compliance matters.

Patton’s career spans nearly three decades in operations and quality assurance, including 14 years in the medical device industry. Patton has successfully developed quality systems for industry leading companies such as Medtronic, Boston Scientific, Siemens and Novartis. Patton currently serves as a senior member of the American Society of Quality.

“Adding Sam to our team is an important step in our continued commitment to delivering quality products to the marketplace,” says CEO Dave Dyell. “His philosophy is very much in sync with ours—that the concept of quality must be integrated into every aspect of how our company does business. We look forward to leveraging his experience and benefiting from his expertise.”

About iSirona
Panama City, Florida-based iSirona (www.isirona.com) helps clinicians make more informed decisions about patients by providing an easy-to-use approach to medical device integration. Using iSirona’s software solution, hospitals can connect virtually any medical device to their CIS, providing clinicians with faster access to more accurate patient information.

###

Read the full story at http://www.prweb.com/releases/iSirona/Samuel_Patton/prweb3919034.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors
2. Trinity Health Appoints Four to Board of Directors Trinity Health Appoints Four to Board of Directors
3. GeoVax Labs Appoints Two Industry Veterans to Board of Directors
4. Bon Secours Charity Health System Appoints Philip A. Patterson As CEO
5. Touro Appoints Alan Kadish, M.D. President and CEO
6. Group Logic, Inc. Appoints New CEO
7. AdvancedMD Appoints William Stone Vice President and General Manager of Billing Services Partner Program
8. FDA Appoints Highly Qualified Scientific Experts to Tobacco Products Scientific Advisory Committee
9. Yayi International Appoints New Chief Financial Officer
10. Quantum Health Appoints Stark as Executive Vice President of Sales
11. Cochlear Appoints Switched on Media to Develop its SEO Across the Asia Pacific Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/27/2017)... ... April 27, 2017 , ... Today, Jefferson Health in ... Colorado, announced an agreement to create the Jane and Leonard Korman Respiratory Institute ... and Leonard Korman Family Foundation. The collaboration leverages the strengths of each organization ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders ... of Thinksport’s award-winning sunscreen they’ve used the same scientific approach to solving smelly, ... deodorants flood the aisles that contain harmful chemicals that should be put nowhere ...
(Date:4/27/2017)... ... April 27, 2017 , ... SyncDog, Inc. , the ... MobileIron Live! 2017 in Santa Clara, California. Each year, MobileIron Live! assembles ... helping organizations maximize the benefits of mobility in their operations securely. MobileIron ...
(Date:4/27/2017)... ... April 27, 2017 , ... Are you investing in ... in water-related accidents and drownings during the summer. While most of us assume this ... situations occur every day. Very few people are taking the time to learn how ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
Breaking Medicine Technology: